Business Wire

Ant Group Achieves 2022 Carbon Neutrality Across Its Operations for the Second Consecutive Year

21.4.2023 15:33:00 EEST | Business Wire | Press release

Share

According to figures certified by the China Environmental United Certification Center (“CEC”), Ant Group has once again achieved operational carbon neutrality (Scope 1 & 2) for the second consecutive year, following the company’s initial achievement in 2021. This marks another concrete step for Ant Group towards fulfilling its pledge made in March 2021 to achieve net zero carbon emissions across Scope 1, 2 & 3 by 2030.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230420006073/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Through a combination of reduction, substitution and offset measures, Ant Group achieved carbon neutrality in Scope 1 & 2 in 2022. (Graphic: Business Wire)

The Greenhouse Gas Protocol (“Protocol”) classifies a company's Greenhouse Gas Emissions (“GHG”) into Scope 1, 2 and 3. Based on the Protocol, Ant Group, in its Carbon Neutrality Road Map, released in April 2021 , defined its GHG emissions scopes as follows:

  • Scope 1: direct & fugitive emissions from the combustion of fossil fuel by the company’s owned or controlled sources.
  • Scope 2: indirect emissions from the consumption of purchased energy, such as heating or cooling networks.
  • Scope 3: indirect emissions which occur in the company's value chain, such as emissions from the use of leased data centers, employees’ business travel and their daily commute.

According to CEC certified figures, in 2022, after reductions and substitutions, Ant Group's greenhouse gas (GHG) emissions for Scope 1 & 2 totaled 21,087.93 tonnes of CO2e, which were fully offset by the company’s purchase of carbon credits from a Verified Carbon Standard (VCS) Project, namely the CECIC Gansu Yumen Changma No.3 Wind Farm Project (VCS Project No.728).

CEC certified figures indicate that Ant Group reduced a total of 68,665.35 tonnes of CO2e across Scope 1, 2 & 3 in 2022, up 81% from 37,909.87 tonnes in 2021. This is equivalent to taking more than 28,000 cars off the road each year, assuming each car is driven 12,000 kilometers per year at 0.203 kilogram of CO2e per kilometer. The CEC was an official service provider to the 2022 Winter Olympics, helping the Olympic Committee measure the effectiveness of its carbon reduction efforts.

This reduction was mainly due to the implementation of green computing technologies. These technologies reduced about 62,000 tonnes of CO2e, which accounted for more than 99% of all carbon emissions reduced in Scope 3 during 2022. This was a 110% improvement over the 30,000 tonnes of CO2e that green computing technologies reduced in 2021.

“At Ant Group, we believe a company’s commercial value creation should go hand in hand with social value creation,“ said Yijie Peng, Chief Sustainability Officer of Ant Group. “Technological innovations has always been an important pathway for us to achieve this goal. We are committed to reaching net zero carbon emissions by 2030 and will continue to explore innovative ways to help reduce our carbon footprint and that of the industry.”

Ant Group has been developing and adopting green computing technologies since 2019. These technologies include Green AI, a series of technologies such as elastic management, GPU memory pooling and virtualization, which make large-scale model training more efficient.

For example, ATorch, Ant Group's PyTorch extension library, can double the utilization rate of AI computing power in large GPU cluster configurations compared to Megatron-DeepSpeed, an opensource deep learning optimization software suite. The use of ATorch has led to energy efficiency gains and carbon emission reductions for AI model training operations, which the company uses to iterate its AI-based products and services for better customer experience.

Ant Group also uses other green computing technologies, such as online-offline hybrid deployment, cloud-native time-shared scheduling, AI-based auto scaling, and OceanBase enterprise-level distributed relational database to help improve energy efficiency of data centers.

In 2022, Ant Group joined the Low Carbon Patent Pledge and granted free patent access to its green computing technologies.

The CEC’s carbon neutrality certificate for Ant Group for the year 2022 is publicly available on the Information Platform for Carbon Neutrality, which is affiliated with the Environmental Development Center of China’s Ministry of Ecology and Environment.

About Ant Group

Ant Group aims to create the infrastructure and platform to support the digital transformation of the service industry. It strives to enable all consumers and small and micro businesses to have equal access to financial and other services that are inclusive, green and sustainable.

For more information, please visit our website at www.antgroup.com or follow us on Twitter @AntGroup.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Enquiries
Zhumei WANG
zhumei.wzm@antgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release

Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release

Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release

Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development

Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye